6 results match your criteria: "University of Medicine Cluj-Napoca 400014[Affiliation]"
Comment on: Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.
Int J Ophthalmol
April 2022
Department of Ophthalmology, University of Medicine Cluj-Napoca 400014, Romania.
Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study.
Int J Ophthalmol
July 2021
Department of Ophthalmology, University of Medicine Cluj-Napoca 400014, Romania.
Comment on "Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography".
Int J Ophthalmol
May 2020
Department of Ophthalmology, University of Medicine Cluj-Napoca 400014, Romania.
Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration".
Int J Ophthalmol
February 2020
Department of Ophthalmology, University of Medicine Cluj-Napoca 400014, Romania.
Comment on "The thickness and volume of the choroid, outer retinal layers and retinal pigment epithelium layer changes in patients with diabetic retinopathy".
Int J Ophthalmol
August 2019
Department of Ophthalmology, University of Medicine Cluj-Napoca 400014, Romania.
Comment on "Intravitreal dexamethasone implants for diabetic macular edema".
Int J Ophthalmol
December 2018
Department of Ophthalmology, University of Medicine Cluj-Napoca 400014, Romania.